On Wednesday, in the course of current trade, Shares of Twitter, Inc. (NYSE:TWTR), dropped -0.22%, and is now trading at $36.43.
Twitter may be mulling a purchase of Flipboard, a social aggregation app that lets users organize articles about the subjects that interest them into their own “digital magazine,” Re/code reports. The possible acquisition would be an all-stock deal that would value Flipboard at more than $1 billion.
Flipboard was co-founded in 2010 by Mike McCue and Evan Doll. Preceding to Flipboard, software engineer Doll worked on the iPhone at Apple and Silicon Valley fixture McCue sold his voice recognition tech startup TellMe Networks to Microsoft for more than $800 million and was a General Manager there.
Twitter, Inc. operates as a global platform for public self-expression and conversation in real time. It offers various products and services for users, counting Twitter that allows users to create, distribute, and discover content; and Vine and video, a mobile application that enables users to create and distribute short looping videos.
During an Afternoon trade, Shares of NVIDIA Corporation (NASDAQ:NVDA), surged 3.76%, and is now trading at $21.51, as the chipmaker enters the fast-growing market of self-driving cars.
The California-based company’s executives said the self-driving car of tomorrow is probably going to look a lot more like today’s models, according to The Wall Street Journal.
Nvidia, a company best known for powering video games with its graphics processors, is now competing with tech giants like Google (GOOGL) and Apple (APPL).
The development kits are being used to assist train self-driving prototypes. While this training process could take years, the kit’s software will eventually teach cars how to tell the difference between a police car and other vehicles, the Journal stated.
NVIDIA Corporation operates as a visual computing company in the United States, Taiwan, China, the rest of Asia Pacific, Europe, and other Americas. The company operates through two segments, GPU and Tegra Processors.
Health Care SPDR (XLV), iShares Dow Jones US Healthcare (IYH) and Vanguard Health Care ETF (VHT) were firmer. Biotech ETF iShares NASDAQ Biotechnology Index (IBB) was up 1.3%.
Shares of Abbott Laboratories (NYSE:ABT), during its Wednesday’s current trading session gained 0.38%, and is now trading at $48.78.
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; intrahepatic cholestasis or depressive symptoms; gynecological disorders; dyslipidemia; hypertension; hypothyroidism; pain, fever, and inflammation; hormone replacement therapy; anti-infective and influenza vaccines; and product that regulates physiological rhythm of the colon.
Finally, Technology stocks were assisting pace gains for the broader U.S. equities indices, with shares of technology companies in the S&P 500 climbing more than 1.0% this afternoon.
Telefonica Brasil, S.A. (NYSE:VIV), gained 0.29% Wednesday. 1,924,728 shares changed hands as compared to its average daily volume of 2,895,880 shares.
Telefônica Brasil S.A. provides fixed-line telecommunications services to residential and corporate customers in Brazil. The company offers voice services, counting activation, monthly subscription, public telephones, and measured services; intraregional, interregional, and international long-distance voice services; data services comprising broadband services; mobile value added services; and Pay TV services through direct to home satellite technology, IPTV, and cable.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.